Centro Multidisciplinar de Estudos Clínicos - CEMEC*X*

Santo André, São Paulo 09190-510

0 studies enrolling now · 2 studies all time

What they study most

Lupus Erythematosus, Systemic, Lupus Nephritis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis — Running, not enrolling
• An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus — Stopped early